US Broker Ratings

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare’s Complexities with a 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC) operates within the intricate landscape of healthcare improvement services, catering to a network of hospitals, health systems, and other healthcare providers. Based in Charlotte, North Carolina,..

Bausch Health Companies Inc. (BHC) Stock Analysis: Unpacking the 4.23% Upside Potential in the Healthcare Sector

Bausch Health Companies Inc. (NYSE: BHC), a prominent name in the healthcare sector, is gaining attention from investors with its potential upside of 4.23%. Specializing in specialty and generic drug..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A 362% Potential Upside Beckons Investors

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning player in the biotechnology sector, is attracting considerable attention from investors with its promising potential upside of 362.16%. Specializing in the development of..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 39.74% Potential Upside for This Biotech Innovator

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company headquartered in Brisbane, California, is drawing investor attention with its focus on transformative treatments for serious immunological diseases. With a current..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Unpacking a 24% Upside Potential in Biotech

Apogee Therapeutics, Inc. (APGE) is catching the eye of investors amid its promising position in the biotechnology sector. With a current market cap of $5.33 billion, this clinical-stage company is..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring the 22.67% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. Headquartered in Burlington, Massachusetts, this company has carved..

Tarsus Pharmaceuticals, Inc. (TARS): Investor Outlook on a Biotech Powerhouse with 146.7% Revenue Growth

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has caught the attention of investors with its dynamic approach to biopharmaceutical innovation, particularly within eye care. As a player in the biotechnology industry, Tarsus..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 22.97% Potential Upside in Biotech

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company based in Morrisville, North Carolina, has been gaining attention in the healthcare sector due to its innovative approach to treating pulmonary diseases. Specializing..

Twist Bioscience Corporation (TWST) Stock Analysis: Revenue Growth Shines Amidst Technical Challenges

Twist Bioscience Corporation (NASDAQ: TWST), a leading player in the healthcare sector’s diagnostics and research industry, has been generating buzz among investors, particularly due to its robust 16.90% revenue growth...

Adaptive Biotechnologies (ADPT) Stock Analysis: Unpacking the 102% Revenue Growth and 14% Potential Upside

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a key player in the biotechnology sector, is capturing investor attention with its remarkable revenue growth and promising stock potential. Situated in the dynamic healthcare..

NovoCure Limited (NVCR) Stock Analysis: Exploring a Potential 84% Upside in the Medical Device Arena

NovoCure Limited (NASDAQ: NVCR), a pioneering force in the healthcare sector, specializes in the development and commercialization of innovative tumor treating fields (TTFields) devices aimed at combating solid tumor cancers...

Select Medical Holdings Corpora (SEM) Stock Analysis: Exploring a 23.57% Potential Upside

Investors searching for opportunities in the healthcare sector might find Select Medical Holdings Corporation (NYSE: SEM) an intriguing prospect. With its diverse range of services and significant market presence, Select..

Alphatec Holdings, Inc. (ATEC) Investor Outlook: Strong Buy Ratings and 18.91% Potential Upside

For investors with a keen eye on the healthcare sector, Alphatec Holdings, Inc. (NASDAQ: ATEC) emerges as a compelling opportunity. With a market capitalization of $3.07 billion, Alphatec is a..

SS Innovations International (SSII) Stock Analysis: Unpacking Rapid Revenue Growth Amid Uncertain Metrics

SS Innovations International Inc. (SSII) is making waves in the healthcare sector, particularly within medical devices. This India-based company is a prominent player in the surgical robotics market, a niche..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 6.28% Potential Upside Amidst Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC) is capturing attention in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. Based in Orange, California, this company is..

Scholar Rock Holding Corporation (SRRK): Investor Outlook on Biotech’s Potential Upside and Robust Buy Ratings

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor interest with its focus on groundbreaking treatments for serious diseases, leveraging its deep expertise in protein growth factors. With a market..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Strong Revenue Growth and Analyst Confidence Signal Promising Upside

Guardian Pharmacy Services, Inc (NASDAQ: GRDN) is making waves in the healthcare sector, particularly within the medical care facilities industry, providing essential pharmacy services to long-term care facilities across the..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Look at Its 7.32% Upside Potential

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, is garnering attention from investors due to its promising growth prospects in the rare disease treatment market. Headquartered..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 21% Potential Upside in the Booming Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, is gaining attention from investors due to its significant growth potential and its robust position in the..

Kymera Therapeutics, Inc. (KYMR): Biotechnology Stock with a 37% Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has become a focal point for investors in the biotechnology sector, driven by its cutting-edge approach to drug development and a significant potential upside. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds